about
Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields.Lanthanide(III) complexes of aminoethyl-DO3A as PARACEST contrast agents based on decoordination of the weakly bound amino group.Lanthanide(III) complexes of novel mixed carboxylic-phosphorus acid derivatives of diethylenetriamine: a step towards more efficient MRI contrast agents.Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate.Ln(iii)-complexes of a DOTA analogue with an ethylenediamine pendant arm as pH-responsive PARACEST contrast agents.Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex.Gadolinium(III) complexes of mono- and diethyl esters of monophosphonic acid analogue of DOTA as potential MRI contrast agents: solution structures and relaxometric studies.A gadolinium(III) complex of a carboxylic-phosphorus acid derivative of diethylenetriamine covalently bound to inulin, a potential macromolecular MRI contrast agent.Pyridine-N-oxide analogues of DOTA and their gadolinium(III) complexes endowed with a fast water exchange on the square-antiprismatic isomer.Gd(iii) complex of a monophosphinate-bis(phosphonate) DOTA analogue with a high relaxivity; Lanthanide(iii) complexes for imaging and radiotherapy of calcified tissues.Complexes of hydrophilic triphenylphosphines modified with gem-bis(phosphonate) moiety. An unusual simultaneous cis and trans arrangements in the Pt(II) dinuclear complex.Mn(2+) complexes with pyridine-containing 15-membered macrocycles: thermodynamic, kinetic, crystallographic, and (1)H/(17)O relaxation studies.Lanthanide(III) complexes of 4,10-bis(phosphonomethyl)-1,4,7,10-tetraazacyclododecane-1,7-diacetic acid (trans-H6do2a2p) in solution and in the solid state: structural studies along the series.Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging.Mn2+ complexes of 1-oxa-4,7-diazacyclononane based ligands with acetic, phosphonic and phosphinic acid pendant arms: stability and relaxation studies.Mn2+ complexes with 12-membered pyridine based macrocycles bearing carboxylate or phosphonate pendant arm: crystallographic, thermodynamic, kinetic, redox, and 1H/17O relaxation studies.Lanthanide(III) complexes that contain a self-immolative arm: potential enzyme responsive contrast agents for magnetic resonance imaging.Cyclam Derivatives with a Bis(phosphinate) or a Phosphinato-Phosphonate Pendant Arm: Ligands for Fast and Efficient Copper(II) Complexation for Nuclear Medical Applications.A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography.Gallium(III) complexes of DOTA and DOTA-monoamide: kinetic and thermodynamic studies.Methylene-bis[(aminomethyl)phosphinic acids]: synthesis, acid-base and coordination properties.Thermodynamic and kinetic study of scandium(III) complexes of DTPA and DOTA: a step toward scandium radiopharmaceuticals.Lanthanide(III) complexes of pyridine-N-oxide analogues of DOTA in solution and in the solid state. A new kind of isomerism in complexes of DOTA-like ligands.Coordination properties of cyclam (1,4,8,11-tetraazacyclotetradecane) endowed with two methylphosphonic acid pendant arms in the 1,4-positions.Eu(III) Complex with DO3A-amino-phosphonate Ligand as a Concentration-Independent pH-Responsive Contrast Agent for Magnetic Resonance Spectroscopy (MRS).Cyclam (1,4,8,11-tetraazacyclotetradecane) with one methylphosphonate pendant arm: a new ligand for selective copper(ii) binding.A bisphosphonate monoamide analogue of DOTA: a potential agent for bone targeting.Paramagnetic 19F Relaxation Enhancement in Nickel(II) Complexes of N-Trifluoroethyl Cyclam Derivatives and Cell Labeling for 19F MRI.Synthesis and characterization of monophosphinic acid DOTA derivative: A smart tool with functionalities for multimodal imaging.Phosphonate-titanium dioxide assemblies: platform for multimodal diagnostic-therapeutic nanoprobes.NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies.Neuro-inflammatory effects of photodegradative products of bilirubin.Lanthanide(iii) complexes of monophosphinate/monophosphonate DOTA-analogues: effects of the substituents on the formation rate and radiolabelling yieldTowards MRI contrast agents responsive to Ca(II) and Mg(II) ions: metal-induced oligomerization of dota-bisphosphonate conjugatesLanthanide(III) Complexes of Phosphorus Acid Analogues of H4DOTA as Model Compounds for the Evaluation of the Second-Sphere Hydration1H NMR relaxivity of aqueous suspensions of titanium dioxide nanoparticles coated with a gadolinium(III) chelate of a DOTA-monoamide with a phenylphosphonate pendant armThermodynamic, kinetic and solid-state study of divalent metal complexes of 1,4,8,11-tetraazacyclotetradecane (cyclam) bearing two trans (1,8-)methylphosphonic acid pendant armsThermodynamic study of lanthanide(III) complexes with bifunctional monophosphinic acid analogues of H4dota and comparative kinetic study of yttrium(III) complexesAnion recognition by alpha-arylazo-N-confused calix[4]pyrrolesThree in one: TSA, TSA', and SA units in one crystal structure of a yttrium(III) complex with a monophosphinated H4dota analogue
P50
Q30571105-FB7299E1-85A2-4890-B4CC-681CDB6FC741Q30667860-D925749D-E3BA-4A8A-9664-53DE5AD46536Q30886117-9CC80D89-653C-49A3-8000-CFA1B99EA399Q30981846-F0402AFE-CD3B-4183-820F-F99DFCD51443Q31038836-44120667-FD15-4EEF-A88A-0F80CA901423Q31048463-43738C6C-9559-4934-A46F-420463F4F6BEQ31090990-5E8F9FD1-278D-4E3E-9FFA-5C6E504F6739Q33204985-4E9C2533-2730-4ADD-9063-1AE347FE226DQ33393817-24D48BBE-3CD2-45D3-A4CC-AD5ADBE99988Q33440687-F2202446-D40C-49AB-A3A8-3BE5723EE2FCQ33491571-05BB5D3F-E828-477C-A035-E4580A827F31Q33533841-1E906B04-4D03-4564-9E50-A47A0842E78DQ33601618-0E2EB948-F096-4737-9C6C-45C93E882600Q33617992-891BB060-2937-4F84-8588-6F28D1BE44E1Q34009907-0860C9C6-C876-4EAB-8504-CE3479F1C417Q34076500-4F23226D-4A54-4F2C-B513-8DA5A497650DQ34115859-5B4365BB-C1F7-4EF6-9D43-9EA01B18DF26Q40264859-7C62540D-725F-48DE-8F8C-C7D3A7DBC27CQ42167262-247E967C-25C5-4796-9CD9-53129E11F2D3Q42837828-12CC9D2B-FBEC-4AAF-8818-E8DDA8C73038Q43887166-084EE5DF-1F36-44C0-89EF-6C2A7325E46BQ44062814-1BE76B76-8B58-4B1F-920B-DF3C5D585200Q46195845-DE13699B-B028-45F2-9D29-CC609B0A58FDQ46337795-5450F3E4-92F0-4F86-ADB5-B9DF031E37AAQ46421840-2B38EE67-A708-40BE-8058-8E7735131849Q46645113-E71FDD79-55D3-4A76-9994-E4B65810A9C6Q46817663-E79CAC38-CAA8-4742-8761-E37093F4E711Q47640994-2E4F9FE6-FE0B-4AC3-9362-22C91DAC117BQ47991017-47475B3C-7A79-4A44-BF59-DBC45612E272Q50678045-443563CE-A815-491C-8B90-2780965518EFQ52371754-929ED989-CB5C-451E-9D27-5298CC2AD5C8Q55339425-346EF848-1795-4729-B132-776197F0D4F5Q56976658-7939B67E-8F31-4439-9690-F17C044006FCQ57391334-0A546D3E-48DC-4E52-B75B-43B9E3E06F16Q57391337-B5D232CC-B5F7-4CCA-A3E1-3EC1D908CC3BQ57391339-CFA258B9-F28E-44EF-8A79-FBB265383911Q79320334-4430E03C-49FA-4092-B7D5-47D50685344FQ79566526-43F04E1F-FAFE-4203-8B78-D942BFABDFB0Q81267528-5EC56BE5-D618-4362-A2E1-1866C5CF9DFEQ82962371-905CA6C4-BC0F-418B-AFE4-7AB54878A3AE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jan Kotek
@ast
Jan Kotek
@en
Jan Kotek
@es
Jan Kotek
@nl
type
label
Jan Kotek
@ast
Jan Kotek
@en
Jan Kotek
@es
Jan Kotek
@nl
prefLabel
Jan Kotek
@ast
Jan Kotek
@en
Jan Kotek
@es
Jan Kotek
@nl
P106
P1153
6701888948
P31
P496
0000-0003-1777-729X